CN103054901A - 透析液及其相关方法和系统 - Google Patents

透析液及其相关方法和系统 Download PDF

Info

Publication number
CN103054901A
CN103054901A CN2012105744771A CN201210574477A CN103054901A CN 103054901 A CN103054901 A CN 103054901A CN 2012105744771 A CN2012105744771 A CN 2012105744771A CN 201210574477 A CN201210574477 A CN 201210574477A CN 103054901 A CN103054901 A CN 103054901A
Authority
CN
China
Prior art keywords
pyrophosphate
type compound
dialysis
acid salt
pyrophosphoric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012105744771A
Other languages
English (en)
Chinese (zh)
Inventor
W·查尔斯·欧内尔
科巴·洛马士威尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of CN103054901A publication Critical patent/CN103054901A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2012105744771A 2003-10-28 2004-10-27 透析液及其相关方法和系统 Pending CN103054901A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51517403P 2003-10-28 2003-10-28
US60/515,174 2003-10-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800390401A Division CN101094681A (zh) 2003-10-28 2004-10-27 透析液及其相关方法和系统

Publications (1)

Publication Number Publication Date
CN103054901A true CN103054901A (zh) 2013-04-24

Family

ID=34572815

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2012105744771A Pending CN103054901A (zh) 2003-10-28 2004-10-27 透析液及其相关方法和系统
CNA2004800390401A Pending CN101094681A (zh) 2003-10-28 2004-10-27 透析液及其相关方法和系统

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA2004800390401A Pending CN101094681A (zh) 2003-10-28 2004-10-27 透析液及其相关方法和系统

Country Status (9)

Country Link
US (1) US20070148258A1 (cg-RX-API-DMAC7.html)
EP (1) EP1682077A4 (cg-RX-API-DMAC7.html)
JP (1) JP4838139B2 (cg-RX-API-DMAC7.html)
KR (1) KR101249707B1 (cg-RX-API-DMAC7.html)
CN (2) CN103054901A (cg-RX-API-DMAC7.html)
AU (1) AU2004287440A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0416088A (cg-RX-API-DMAC7.html)
CA (1) CA2544235C (cg-RX-API-DMAC7.html)
WO (1) WO2005044189A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8187467B2 (en) * 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
EP2206504A4 (en) 2007-10-05 2014-02-12 Univ Chiba Nat Univ Corp STABLE IONIC BICARBONATE MEDICINES SOLUTION
US7658952B2 (en) * 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates
ES2332636B1 (es) * 2008-08-06 2011-02-10 Universitat De Les Illes Balears Composicion de liquido de dialisis.
JP5258448B2 (ja) * 2008-08-12 2013-08-07 扶桑薬品工業株式会社 透析用製剤
AU2015200995B2 (en) * 2010-04-23 2016-09-08 Vantive Health Gmbh Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
EP2560663B1 (en) * 2010-04-23 2016-06-22 Baxter International Inc. Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
CN102517635B (zh) * 2012-01-12 2014-12-24 中国科学院新疆理化技术研究所 化合物锂钾磷氧和锂钾磷氧晶体及其制备方法
EP2862583A1 (en) * 2013-10-17 2015-04-22 Gambro Lundia AB Perm selective membrane for treating vascular calcification in chronic hemodialysis patients
DE102015007842A1 (de) * 2015-06-18 2016-12-22 Fresenius Medical Care Deutschland Gmbh Dialyselösung
US20200009163A1 (en) * 2017-03-06 2020-01-09 University Of Houston System Polyphosphates as inhibitors of calcium crystallization
IT201700085412A1 (it) * 2017-07-26 2019-01-26 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
MX2021003653A (es) 2018-10-11 2021-06-23 Sanifit Therapeutics S A Inositol fosfatos para el tratamiento de calcificacion ectopica.
IT201900007329A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
CN118416279B (zh) * 2024-04-23 2025-09-02 大连医科大学附属第二医院 一种预防血管钙化的动静脉内瘘外用敷料及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9903442A3 (en) * 1996-02-08 2001-11-28 Warner Lambert Co Anticalculus dentifrice containing highly soluble pyrophosphate
AU736053B2 (en) * 1996-12-31 2001-07-26 Ajay Gupta Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
US6689275B1 (en) * 1996-12-31 2004-02-10 Ajay Gupta Method and pharmaceutical composition for replacing iron losses in dialysis patients
US6779468B1 (en) * 1997-08-07 2004-08-24 Ajay Gupta Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
EP1009452A4 (en) * 1997-08-07 2004-03-31 Ajay Gupta WATER-SOLUBLE VITAMINS AND DIALYSIS SOLUTION CONTAINING NUTRIENTS
JP2003519183A (ja) * 2000-01-04 2003-06-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓および動脈の石灰化を抑制する低用量ビスホスホネートの使用
JP2002249433A (ja) * 2000-12-19 2002-09-06 Sumitomo Pharmaceut Co Ltd 血管石灰化抑制剤
US20040241249A1 (en) 2001-06-18 2004-12-02 Tina Sampalis Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport
US6524788B1 (en) * 2001-11-02 2003-02-25 Thomas L. Cantor Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
US8187467B2 (en) * 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AJAY GUPTA,ET AL: "Dialysate iron therapy:Infusion of soluble ferric pyrophophate via the dialysate during hemodialysis", 《KIDNEY INTERNATIONAL》 *
H. FLEISCH,ET AL: "Inhibiton of Aortic Calcification by means of Pyrophosphate and Polyphosphates", 《NATURE》 *
HERBERT FLEISCH,ET AL: "Mechanism of Calcilication:Inhibitory Role of Pyrophosphate", 《NATURE》 *
R. GRAHAM,ET AL: "Pyrophosphate and Diphosphonates in Calcium Metabolism and Theri Possible Role in Renal Failure", 《ARCH. INTERN. MED.》 *

Also Published As

Publication number Publication date
EP1682077A2 (en) 2006-07-26
EP1682077A4 (en) 2009-07-01
CA2544235C (en) 2013-12-10
WO2005044189A2 (en) 2005-05-19
JP4838139B2 (ja) 2011-12-14
JP2007523056A (ja) 2007-08-16
US20070148258A1 (en) 2007-06-28
CN101094681A (zh) 2007-12-26
AU2004287440A1 (en) 2005-05-19
BRPI0416088A (pt) 2007-01-02
KR101249707B1 (ko) 2013-04-05
KR20070014110A (ko) 2007-01-31
CA2544235A1 (en) 2005-05-19
WO2005044189A3 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
JP4838139B2 (ja) 透析液並びに透析液に関連した方法及びシステム
Dhar et al. Effects of hematin in hepatic porphyria: further studies
JP2007523056A5 (cg-RX-API-DMAC7.html)
US5474992A (en) Method of treatment with pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis
EA018245B1 (ru) Органические соединения трехвалентного железа фармацевтического качества, их применение и способы их получения
CN106588928A (zh) 新型七环化合物,其合成,活性评价及应用
US20160106713A1 (en) Nitric oxide scavengers
CN115379841A (zh) 治疗呼吸系统病症的trpc6抑制剂
JP2023510865A (ja) 血管脂肪腫の処置のための組成物
KR20190003319A (ko) 섬유화증 예방, 개선 또는 치료용 조성물
KR20210020930A (ko) 노화 세포에 의해 유발되거나 매개되는 병태의 임상 관리에서의 사용 및 암 치료를 위한 bcl 패밀리 길항제인 아실 설폰아마이드
AU735980B2 (en) A method of treating liver disease and like indications with vasodilating agents
CN113521060B (zh) 鱼针草内酯抗新型冠状病毒的用途
TWI754260B (zh) 魚針草內酯抗新型冠狀病毒之用途
US12403125B2 (en) Use of Ovatodiolide against SARS-CoV-2
TW200306811A (en) Medicinal compositions for inhibiting tryptase
RU2358731C2 (ru) Cci-779 для лечения лимфомы из мантийных клеток
KR20190085946A (ko) 트리시클릭 유도체 또는 이의 약학적으로 허용 가능한 염을 포함하는 허혈성 급성 신 손상 예방 또는 치료용 약학적 조성물
MXPA06004730A (en) Dialysates and methods and systems related thereto
KR100379596B1 (ko) 구연산칼륨을 주제로 한 요로결석치료제의 제조방법
CN103417554A (zh) 一种抗肿瘤的药物组合物及其应用
CN112999233A (zh) 一类来源于赤芍的单萜苷类化合物及其制法和应用
Nagura et al. Me3221, a surmountable angiotensin at1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats
KR20060066176A (ko) 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 신기능 치료제 조성물
KR20120119014A (ko) 경련성 질환 치료 및 예방용 약학조성물

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130424